Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cui-Yun Yu

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Advanced Healthcare Materials|March 22, 2024
An "All-In-One" Immunomodulator-Engineered Clinical Translatable Immunotherapy of Advanced Hepatocellular CarcinomaTing Xie, Cong Huang, Yuqing Wang, et al.
International Journal of Pharmaceutics|September 17, 2022
Review of lipoic acid: From a clinical therapeutic agent to various emerging biomaterialsShao-Yang Lv, Suisui He, Xiao-Li Ling, et al.
RSC Advances|May 11, 2022
Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin-doxorubicin conjugates macromolecular pro-drug for targeted cancer therapyZhi-Ping Li, Ming-Chao Jiang, Bo Chen, et al.
ACS Applied Materials & Interfaces|February 26, 2019
Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular CarcinomaQian Ning, Yu-Feng Liu, Peng-Ju Ye, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 12, 2018
Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapyPeng-Ju Ye, Can Huang, Sa Yang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2022
Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivoYue-Qing Wang, Cong Huang, Peng-Ju Ye, et al.
Drug Delivery|February 22, 2017
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapyCan Huang, Na-Mei Li, Pei Gao, et al.
Biomaterials Advances|May 30, 2026
An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancerZhen Cao, Xiao-Jie Wei, Luan-Feng Liao, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Advanced Healthcare Materials|March 22, 2024
An "All-In-One" Immunomodulator-Engineered Clinical Translatable Immunotherapy of Advanced Hepatocellular CarcinomaTing Xie, Cong Huang, Yuqing Wang, et al.
International Journal of Pharmaceutics|September 17, 2022
Review of lipoic acid: From a clinical therapeutic agent to various emerging biomaterialsShao-Yang Lv, Suisui He, Xiao-Li Ling, et al.
RSC Advances|May 11, 2022
Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin-doxorubicin conjugates macromolecular pro-drug for targeted cancer therapyZhi-Ping Li, Ming-Chao Jiang, Bo Chen, et al.
ACS Applied Materials & Interfaces|February 26, 2019
Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular CarcinomaQian Ning, Yu-Feng Liu, Peng-Ju Ye, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 12, 2018
Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapyPeng-Ju Ye, Can Huang, Sa Yang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2022
Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivoYue-Qing Wang, Cong Huang, Peng-Ju Ye, et al.
Drug Delivery|February 22, 2017
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapyCan Huang, Na-Mei Li, Pei Gao, et al.
Biomaterials Advances|May 30, 2026
An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancerZhen Cao, Xiao-Jie Wei, Luan-Feng Liao, et al.
Pageof 8